Determination of the mechanism of action of repetitive halothane exposure on rat brain tissues using a combined method of microarray gene expression profiling and bioinformatics analysis

Wang,Jiansheng; Yang,Xiaojun; Xiao,Huan; Kong,Jianqiang; Bing,Miao

doi:10.3892/mmr.2015.4462

Determination of the mechanism of action of repetitive halothane exposure on rat brain tissues using a combined method of microarray gene expression profiling and bioinformatics analysis

Authors:
- Jiansheng Wang
- Xiaojun Yang
- Huan Xiao
- Jianqiang Kong
- Miao Bing
View Affiliations

Affiliations: Department of Anesthesiology, Shanghai Baoshan District Integrated Traditional and Western Medicine Hospital, Shanghai 201900, P.R. China
Published online on: October 21, 2015 https://doi.org/10.3892/mmr.2015.4462
Pages: 8071-8076

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the gene expression profiles of rats brain tissues treated with halothane compared with untreated controls to improve current understanding of the mechanism of action of the inhaled anesthetic. The GSE357 gene expression profile was dowloaded from the Gene Expression Omnibus database, and included six gene chips of samples repeatedly exposed to halothane and 12 gene chips of untreated controls. The differentially expressed genes (DEGs) between these two groups were identified using the Limma package in R language. Subsequently, the Database for Annotation, Visualization and Integrated Discovery was used to annotate the function of these DEGs. In addition, the most significantly upregulated gene and downregulated gene were annotated, to reveal the functional interactions with other associated genes, in FuncBase database. A total of 44 DEGs were obtained between The control and halothane exposure samples. Following Gene Ontology functional classification, these DEGs were found to be involved predominantly in the circulatory system, regulation of cell proliferation and response to endogenous stimulus and corticosteroid stimulus processes. KRT31 and HMGCS2, which were identified as the most significantly downregulated and upregulated DEGs, respectively, were associated with the lipid metabolic process and T cell activation, respectively. These results provided a basis for the development of improved inhalational anesthetics with minimal side effects and are essential for optimization of inhaled anesthetic techniques for advanced surgical procedures.

View Figures

View References

1	Weiser TG, Regenbogen SE, Thompson KD, et al: An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 372:139–144. 2008. View Article : Google Scholar : PubMed/NCBI
2	Eger EI 2nd and Sonner JM: Anaesthesia defined (gentlemen,this is no humbug). Best Pract Res Clin Anaesthesiol. 20:23–29. 2006. View Article : Google Scholar : PubMed/NCBI
3	Richter J, Landau EM and Cohen S: The action of volatile anesthetics and convulsants on synaptic transmission: A unified concept. Mol Pharmacol. 13:548–559. 1977.PubMed/NCBI
4	Alkire MT, Pomfrett CJ, Haier RJ, et al: Functional brain imaging during anesthesia in humans: effects of halothane on global and regional cerebral glucose metabolism. Anesthesiology. 90:701–709. 1999. View Article : Google Scholar : PubMed/NCBI
5	Matsumoto N, Koizumi M and Sugai M: Hepatolobectomy-induced depression of hepatic circulation and metabolism in the dog is counteracted by isoflurane, but not by halothane. Acta Anaesthesiol Scand. 43:850–854. 1999. View Article : Google Scholar : PubMed/NCBI
6	Harrfeldt HP: Acute liver failure following repeated halothane anesthesia-related to an accident covered by industrial insurance. Monatsschr Unfallheilkd Versicher Versorg Verkehrsmed. 72:3171969.In German.
7	Lo SK, Wendon J, Mieli-Vergani G and Williams R: Halothane-induced acute liver failure: continuing occurrence and use of liver transplantation. Eur J Gastroenterol Hepatol. 10:635–639. 1998.PubMed/NCBI
8	Wessler S: Halothane and liver failure. JAMA. 213:1291970. View Article : Google Scholar : PubMed/NCBI
9	Hemmings HC Jr, Akabas MH, Goldstein PA, Trudell JR, Orser BA and Harrison NL: Emerging molecular mechanisms of general anesthetic action. Trends Pharmacol Sci. 26:503–510. 2005. View Article : Google Scholar : PubMed/NCBI
10	Nishikawa K, Jenkins A, Paraskevakis I and Harrison NL: Volatile anesthetic actions on the GABAA receptors: contrasting effects of alpha 1 (S270) and beta 2 (N265) point mutations. Neuropharmacology. 42:337–345. 2002. View Article : Google Scholar : PubMed/NCBI
11	Gomez RS, Guatimosim C and Gomez MV: Mechanism of action of volatile anesthetics: role of protein kinase C. Cell Mol Neurobiol. 23:877–885. 2003. View Article : Google Scholar
12	Hemmings HC Jr and Adamo AI: Effects of halothane and propofol on purified brain protein kinase C activation. Anesthesiology. 81:147–155. 1994. View Article : Google Scholar : PubMed/NCBI
13	Maingret F, Patel AJ, Lesage F, Lazdunski M and Honoré E: Mechano- or acid stimulation, two interactive modes of activation of the TREK-1 potassium channel. J Biol Chem. 274:26691–26696. 1999. View Article : Google Scholar : PubMed/NCBI
14	Eckenhoff RG and Shuman H: Localization of volatile anesthetic molecules at the subcellular and molecular level. Ann N Y Acad Sci. 625:755–756. 1991. View Article : Google Scholar : PubMed/NCBI
15	Xi J, Liu R, Asbury GR, Eckenhoff MF and Eckenhoff RG: Inhalational anesthetic-binding proteins in rat neuronal membranes. J Biol Chem. 279:19628–19633. 2004. View Article : Google Scholar : PubMed/NCBI
16	Chepovetsky J, Kalir T and Weiderpass E: Clinical applicability of microarray technology in the diagnosis, prognostic stratification, treatment and clinical surveillance of cervical adenocarcinoma. Curr Pharm Des. 19:1425–1429. 2013.
17	Pan JZ, Wei H, Hecker JG, Tobias JW, Eckenhoff RG and Eckenhoff MF: Rat brain DNA transcript profile of halothane and isofurane exposure. Pharmacogenet Genomics. 16:171–182. 2006.PubMed/NCBI
18	Xia X, Mcclelland M and Wang Y: WebArray: an online platform for microarray data analysis. BMC Bioinformatics. 6:3062005. View Article : Google Scholar : PubMed/NCBI
19	Fernandez P, Soria M, Blesa D, et al: Development, characterization and experimental validation of a cultivated sunfower (Helianthus annuus L.) gene expression oligonucleotide microarray. PLoS One. 7:e458992012. View Article : Google Scholar
20	Ashburner M, Ball CA, Blake JA, et al: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
21	Brown DL and Brock-Utne JG: The first structure-function approach to drug design in anaesthesia. Dr David S Savage and pancuronium bromide. Anaesthesia. 52:1202–1204. 1997. View Article : Google Scholar
22	Quentien MH, Delemer B, Papadimitriou DT, et al: Deficit in anterior pituitary function and variable immune deficiency (DAVID) in children presenting with adrenocorticotropin deficiency and severe infections. J Clin Endocrinol Metab. 97:E121–E128. 2012. View Article : Google Scholar
23	Beaver JE, Tasan M, Gibbons FD, Tian W, Hughes TR and Roth FP: FuncBase: a resource for quantitative gene function annotation. Bioinformatics. 26:1806–1807. 2010. View Article : Google Scholar : PubMed/NCBI
24	Shakouri P, Ordys A and Askari MR: Adaptive cruise control with stop & go function using the state-dependent nonlinear model predictive control approach. ISA Trans. 51:622–631. 2012. View Article : Google Scholar : PubMed/NCBI
25	Wang J, Zhou X, Zhu J, et al: GO-function: deriving biologically relevant functions from statistically significant functions. Brief Bioinform. 13:216–227. 2012. View Article : Google Scholar
26	Wright J, Morales MM, Sousa-Menzes J, et al: Transcriptional adaptation to Clcn5 knockout in proximal tubules of mouse kidney. Physiol Genomics. 33:341–354. 2008. View Article : Google Scholar : PubMed/NCBI
27	Medzhitov R and Janeway C Jr: Innate immune recognition: mechanisms and pathways. Immunol Rev. 173:89–97. 2000. View Article : Google Scholar : PubMed/NCBI
28	Park JS, Svetkauskaite D, He Q, et al: Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem. 279:7370–7377. 2004. View Article : Google Scholar
29	Dugan CM, Fullerton AM, Roth RA and Ganey PE: Natural killer cells mediate severe liver injury in a murine model of halothane hepatitis. Toxicol Sci. 120:507–518. 2011. View Article : Google Scholar : PubMed/NCBI
30	Scaffidi P, Misteli T and Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 418:191–195. 2002. View Article : Google Scholar : PubMed/NCBI
31	Nyirenda MJ, Lind say RS, Kenyon CJ, Burchell A and Seckl JR: Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Invest. 101:2174–2181. 1998. View Article : Google Scholar : PubMed/NCBI
32	Agresti A, Scaffidi P, Riva A, Caiolfa VR and Bianchi ME: GR and HMGB1 interact only within chromatin and influence each other's residence time. Mol Cell. 18:109–121. 2005. View Article : Google Scholar : PubMed/NCBI
33	Loranger A, Duclos S, Grenier A, et al: Simple epithelium keratins are required for maintenance of hepatocyte integrity. Am J Pathol. 151:1673–1683. 1997.PubMed/NCBI
34	Asch HL, Mayhew E, Lazo RO and Asch BB: Lipids covalently bound to keratins of mouse mammary epithelial cells. Biochem Mol Biol Int. 29:1161–1169. 1993.PubMed/NCBI